Three Meningitis B Cases Confirmed in Dorset as Young People Offered Vaccines and Antibiotics Three confirmed cases of meningitis B (MenB) have been identified in young people in Weymouth, Dorset, prompting a targeted public health response from the UK Health Security Agency (UKHSA). The cases were confirmed between 20 March and 15 April 2026 and involve students from Budmouth Academy and Wey Valley Academy. All individuals have received treatment and are recovering well. In response, UKHSA is working with Dorset Council, the NHS and local partners to offer antibiotics and the MenB vaccine as a precautionary measure. Close contacts of the cases have already been offered antibiotics. The vaccination and antibiotic offer is now being extended to young people in school years 7 to 13 (or equivalent), or anyone not in full-time education who would be in those year groups, who study in or live in the Weymouth, Portland, and Chickerell areas of Dorset. The three cases have been confirmed as the same sub-strain of MenB bacteria, though this sub-strain is different from the one recently detected in Kent. While two of the cases at Budmouth Academy are known to be contacts of each other, no confirmed epidemiological link has been established between these cases and the third case at Wey Valley Academy. This raises the possibility of wider transmission among young people in the area, prompting the expanded precautionary offer. Dr Beth Smout, UKHSA Deputy Director, emphasized that the action follows national guidelines and is intended to reduce the risk of further spread. She noted that while there is concern among students, staff, parents, and the local community, school pupils and staff should attend school as normal if they remain well. Around 300 to 400 cases of meningococcal disease are diagnosed in England each year. Meningitis B is a serious bacterial infection that can cause meningitis and septicaemia (blood poisoning), particularly in young people. Early symptoms include fever, headache, vomiting, muscle pain, and cold hands and feet. A rash that does not fade under pressure may appear in later stages. Immediate medical attention is critical if meningitis is suspected. The MenB vaccine is part of the routine childhood immunisation schedule in the UK, offered to infants at 8 weeks, 16 weeks, and 1 year of age. However, older adolescents who did not receive the vaccine as part of the routine programme may still be eligible under targeted outreach programmes like this one in Dorset. Public health officials continue to monitor the situation closely and urge anyone experiencing symptoms of meningitis to seek medical help immediately. Further information about the signs and symptoms of meningitis has been shared with students and parents at the affected schools.
24